Skip to main content

Closed

REPL: Replimune Group, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-114.8%

Financially safe

Stretched

Debt / equity0.17×

Interest coverage-36.1×

Current ratio4.79×

Replimune Group, Inc.

REPLNASDAQ Global Select·USD·Closed

Replimune Group, Inc.

REPLNASDAQ·USD·Closed

$11.20

+107.02%

$11.20

+$5.79 (107.02%)

52W Range

88thpctl

Volume

5.61×avg

Mkt Cap

940.40MUSD

P/E

-3.3TTM

Div Yield

–ann

52W Range

88thpctl

Volume

5.61×avg

Market Cap

940.40MUSD

P/E Ratio

-3.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings